These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35484878)

  • 1. Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations.
    Mack JM; Peterson EC; Crary SE; Moran JH; Neville K; Pierce CD; Richter GT
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29733. PubMed ID: 35484878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin.
    Yang WH; Xiang XJ; Li HL
    Phlebology; 2023 Aug; 38(7):451-457. PubMed ID: 37318342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous sclerotherapy using bleomycin for the treatment of vascular malformations.
    Lee HJ; Kim TW; Kim JM; Kim GW; Ko HC; Kim BS; Kim MB; Kim HS
    Int J Dermatol; 2017 Nov; 56(11):1186-1191. PubMed ID: 28869282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
    Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic transmucosal direct puncture sclerotherapy for management of airway vascular malformations.
    Oomen KP; Paramasivam S; Waner M; Niimi Y; Fifi JT; Berenstein A; O TM
    Laryngoscope; 2016 Jan; 126(1):205-11. PubMed ID: 25970858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term side effects and patient-reported outcomes of bleomycin sclerotherapy in vascular malformations.
    Mack JM; Richter GT; Becton D; Salem O; Hill SEM; Crary SE
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27008. PubMed ID: 29431255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional bleomycin injection in management of low flow vascular malformations in children.
    Mohan AT; Adams S; Adams K; Hudson DA
    J Plast Surg Hand Surg; 2015 Apr; 49(2):116-20. PubMed ID: 25204206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative outcomes for sclerotherapy of head and neck venous vascular malformation between alcohol and bleomycin.
    Songsaeng D; Churojana A; Khumthong R; Mahiwan L
    J Med Assoc Thai; 2015 Apr; 98(4):408-13. PubMed ID: 25958717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular treatment of slow-flow vascular malformations.
    Burrows PE
    Tech Vasc Interv Radiol; 2013 Mar; 16(1):12-21. PubMed ID: 23499128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy.
    Shigematsu T; Sorscher M; Dier EC; Berenstein A
    J Neurointerv Surg; 2019 Jan; 11(1):57-61. PubMed ID: 29674482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection.
    Hassan Y; Osman AK; Altyeb A
    Ann Plast Surg; 2013 Jan; 70(1):70-3. PubMed ID: 23249476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts in diagnosis and treatment of venous malformations.
    Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin sclerotherapy for lymphatic malformation after unsuccessful surgical excision: case report.
    Vlahovic A; Gazikalovic A; Adjic O
    Acta Otorhinolaryngol Ital; 2015 Oct; 35(5):365-7. PubMed ID: 26824921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Reported Outcomes of Bleomycin Sclerotherapy for Low-Flow Vascular Malformations and Predictors of Improvement.
    Horbach SER; van de Ven JS; Nieuwkerk PT; Spuls PI; van der Horst CMAM; Reekers JA
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1494-1504. PubMed ID: 29948003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of foam and liquid bleomycin in the management of venous malformations in head and neck region: A comparative study.
    Helal HA; Mahmoud NA
    J Plast Reconstr Aesthet Surg; 2020 Jan; 73(1):90-97. PubMed ID: 31201109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Bleomycin Slow Infusion Sclerotherapy Using a Syringe Pump for Microcystic and Mixed Lymphatic Malformations.
    Cha JG; Lee J; Lee SY; Chung HY; Lee SJ; Huh S; Kim JY; Hong J
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1288-1294. PubMed ID: 35864208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicoradiologic predictors of sclerotherapy response in low-flow vascular malformations.
    Bagga B; Goyal A; Das A; Bhalla AS; Kandasamy D; Singhal M; Kairo A
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):209-219.e2. PubMed ID: 32653406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional injection of bleomycin in the management of low flow vascular malformations: Results and factors affecting the outcome.
    Abdelaty MH; Badran AI; Aborahma AM; Elheniedy MA; Kamhawy AH
    J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101694. PubMed ID: 37890586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Nd:YAG laser and bleomycin sclerotherapy under the same anesthesia for cervicofacial venous malformations: A safe and effective treatment option.
    Gregory S; Burrows PE; Ellinas H; Stadler M; Chun RH
    Int J Pediatr Otorhinolaryngol; 2018 May; 108():30-34. PubMed ID: 29605361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.